VHL and neoplasm: An interesting observation was about a frameshift mutation, c.270dupC, in VHL in patient P11, where allele frequency of this mutation was much higher in both liquid biopsy fractions compared to that of tumor DNA (3%, 20%, and 21.5% in tumor, cfDNA, and evDNA, respectively (Figure 4B).